Skip to Main Content
Legislation Search

S. 3739: Veterans Hearing Aid Improvement Act of 2026

This bill is known as the Veterans Hearing Aid Improvement Act of 2026. Its primary objective is to establish a demonstration project to evaluate the potential impact of covering over-the-counter hearing aids for veterans through the Department of Veterans Affairs (VA). Here are the main components:

Demonstration Project

  • The Secretary of Veterans Affairs will start a project within one year of the bill's passage to assess the fiscal consequences of including FDA-cleared over-the-counter hearing aids in the services covered by the VA, similarly to how prescription hearing aids are currently covered.
  • This demonstration project will last for two years.

Eligibility for Participation

Veterans can participate in the demonstration project if they meet the following criteria:

  1. They are enrolled in the VA’s annual patient enrollment system.
  2. An audiologist has determined that they require an over-the-counter hearing aid for mild-to-moderate hearing loss and that they do not have any conditions that would prevent the safe use of such devices.
  3. They have access to a mobile phone or similar technology needed to operate the hearing aid.

Locations for the Project

  • The demonstration will be conducted at a minimum of two VA medical facilities that have been selected for their ability to serve diverse veteran populations, including those in rural and urban areas.

Design of the Project

The project will be designed to compare the effectiveness of FDA-cleared over-the-counter hearing aids with prescription hearing aids that are professionally fitted by audiologists. The VA will assess both the effectiveness and the financial implications of providing permanent coverage for over-the-counter hearing aids.

Measurement of Benefits

The project will include measuring both self-reported benefits from the veterans participating and their ability to recognize speech in noisy environments. This evaluation will be aimed at understanding the long-term impact of providing coverage for over-the-counter hearing aids.

Consultation and Reporting

During the project, the Secretary of Veterans Affairs will consult with organizations that advocate for consumers with hearing loss. Additionally, they must submit:

  • An interim report detailing initial findings within one year of the project's commencement.
  • A final report, which must be submitted within 180 days after the project ends, that evaluates the fiscal impact of covering over-the-counter hearing aids and may include recommendations for future policies.

Study by the Comptroller General

In conjunction with the demonstration project, the Comptroller General of the United States will undertake a study focusing on veterans with mild-to-moderate hearing loss, analyzing their access to hearing aids and related medical coverage. This study will aim to:

  • Assess the number of veterans needing assistive devices.
  • Review the effectiveness of current medical coverage for these devices.
  • Provide recommendations for potential program improvements to meet veterans' needs.

Definition of FDA-Cleared, Over-the-Counter Hearing Aids

The bill defines these devices as:

  • Cleared by the FDA.
  • Subject to FDA regulation under specified federal laws.
  • Equipped with technology that enables personalization through tools like hearing tests and software applications.

Relevant Companies

  • HSIC - Henry Schein Inc.: As a supplier of healthcare products, including hearing aids, this company could see changes in demand based on the outcomes of the demonstration and subsequent coverage decisions for over-the-counter options.
  • SONO - Sonova Holding AG: A manufacturer of hearing aids that could potentially be impacted if the VA chooses to include over-the-counter models in their coverage plans.
  • DEO - Demant A/S: This company offers hearing aids and solutions, which may be affected by shifts in market demand should the VA implement new policies based on the project findings.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

3 bill sponsors

Actions

2 actions

Date Action
Jan. 29, 2026 Introduced in Senate
Jan. 29, 2026 Read twice and referred to the Committee on Veterans' Affairs.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Feb 06, 2026 Jan 29, 2026 +4.99%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN INC
Sale $15,001 - $50,000
Feb 11, 2026 Jan 09, 2026 +0.77%
Congress pfp
Lisa C. McClain R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Oct 22, 2025 Sep 25, 2025 -21.11%
Congress pfp
Val T. Hoyle D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Oct 10, 2025 Sep 23, 2025 -22.49%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Oct 15, 2025 Sep 22, 2025 -21.69%
Congress pfp
Lisa C. McClain R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Purchase $1,001 - $15,000
Oct 22, 2025 Sep 11, 2025 -29.03%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 11, 2025 Aug 21, 2025 +5.20%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 11, 2025 Aug 21, 2025 +5.20%
Congress pfp
Lisa C. McClain R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Sep 12, 2025 Aug 04, 2025 -29.25%
Congress pfp
Lisa C. McClain R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 -35.33%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
May 12, 2025 Apr 15, 2025 -7.01%
Congress pfp
Robert Bresnahan R / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -14.09%
Congress pfp
Julie Johnson D / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Sale $1,001 - $15,000
May 14, 2025 Apr 01, 2025 -9.85%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Sale $1,001 - $15,000
Apr 07, 2025 Mar 31, 2025 -9.38%
Congress pfp
George Whitesides D / House
DEO logo
DEO STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. DIAGEO PLC COMMON STOCK
Sale $15,001 - $50,000
Apr 23, 2025 Mar 24, 2025 -44.86%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -48.04%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -48.04%
Congress pfp
Kelly Morrison D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 20, 2025 -48.04%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 19, 2025 -46.78%
Congress pfp
Sheri Biggs R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Oct 05, 2025 Mar 18, 2025 -49.07%
Congress pfp
Julie Johnson D / House
SONO logo
SONO SONOS, INC. - COMMON STOCK
Sale $1,001 - $15,000
Apr 14, 2025 Mar 11, 2025 -1.97%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -13.15%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 -8.76%
Congress pfp
Tommy Tuberville R / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Feb 14, 2025 Jan 10, 2025 -50.93%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 15, 2024 -4.44%
Congress pfp
Val T. Hoyle D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Purchase $1,001 - $15,000
Sep 12, 2025 Oct 29, 2024 -56.43%
Congress pfp
John James R / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -62.44%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 16, 2024 Aug 26, 2024 -12.71%
Congress pfp
Michael T. McCaul R / House
HSIC logo
HSIC HENRY SCHEIN, INC.
Sale $1,001 - $15,000
Sep 16, 2024 Aug 26, 2024 -12.71%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -62.92%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DC DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -62.92%
Congress pfp
Ro Khanna D / House
DEO logo
DEO DIAGEO ADR
Sale $1,001 - $15,000
Jul 08, 2024 Jun 26, 2024 -62.92%
Congress pfp
Josh Gottheimer D / House
DEO logo
DEO DIAGEO PLC COMMON STOCK
Sale $1,001 - $15,000
Jul 09, 2024 Jun 18, 2024 -62.91%
Congress pfp
Ro Khanna D / House
HSIC logo
HSIC HENRY SCHEIN INC COMMON STOCK
Sale $1,001 - $15,000
Jun 05, 2024 May 29, 2024 -19.25%
Congress pfp
Sheldon Whitehouse D / Senate
DEO logo
DEO Diageo Plc ADR
Sale (Full) $15,001 - $50,000
Jun 06, 2024 May 08, 2024 -74.80%